Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival

J Clin Oncol. 1985 Apr;3(4):490-4. doi: 10.1200/JCO.1985.3.4.490.

Abstract

Primary lymphomas of the CNS are rare tumors accounting for less than 2% of all extranodal non-Hodgkin's lymphomas. The treatment for this disease has been disappointing. Radiation therapy and surgery have produced consistently poor control of this disease, with a median survival of 15 months. We have reviewed ten cases of primary lymphoma of the CNS treated at the Joint Center for Radiation Therapy or Dana-Farber Cancer Institute (Boston) from 1968 to 1981. All patients had biopsy-proven CNS lymphomas without systemic disease at presentation. In our series, control of CNS lymphoma was seen only in patients receiving craniospinal radiation or CNS-penetrating chemotherapy.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Brain Neoplasms / mortality*
  • Brain Neoplasms / therapy
  • Child
  • Combined Modality Therapy
  • Dose-Response Relationship, Radiation
  • Female
  • Humans
  • Lymphoma / mortality*
  • Lymphoma / therapy
  • Male
  • Middle Aged
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local
  • Spinal Cord Neoplasms / mortality*
  • Spinal Cord Neoplasms / therapy